Pharmacokinetic evaluation of linezolid administered intravenously in obese patients with pneumonia

Abstract

Standard linezolid dosing is likely to provide insufficient target attainment against MRSA in obese patients. Body weight and especially age are important characteristics to be considered when administering linezolid to treat MRSA infections.